Printer Friendly
The Free Library
14,680,088 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Novartis Creates Japanese Holding Company.


Tokyo, Japan, Oct 21, 2005 - (JCNN JCNN Japan Corporate News Network ) - Novartis Pharma announced on October 20 that Novartis Holding AG established a new wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 in Japan on October 19. Novartis Holding Japan now oversees the operations of Novartis Pharma, Novartis Pharma's subsidiary Nihon Ciba-Geigy, CIBA Vision To meet Wikipedia's and conform with our NPOV policy, this article or section may require cleanup.
The current version of this article reads like an advertisement.
Please discuss this issue on the . is available.
 Japan and Novartis Animal Health.

With this move, Novartis aims to revitalize operations as a group, making increased efforts to coordinate the operations among the group companies and promote corporate compliance.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Oct 23, 2005
Words:91
Previous Article:Sato Pharmaceutical to Market New Health Maintenance Food Rich with DHA and EPA.
Next Article:Mediaseek to Provide QR Code Reader Application for Taiwan Mobile's Cellular Handsets.



Related Articles
SYNGENTA'S FOCUS WILL MAKE IT ACTIVE, DYNAMIC ADVOCATE FOR AG.(interview with Syngenta vice president, Scott Parker)(Brief Article)
Novartis Animal Vaccines. (Marketing People).(Bruce Van Der Kamp)(Brief Article)
NOVARTIS SANDOSTATIN LAR APPROVED IN JAPAN FOR ACROMEGALY.
Who's winning the game?(Editor's Note)(Editorial)
Keeping the pipeline full: thanks to its indefatigable CEO, Novartis's R & D effort is paying off.(Innovation)(Food and Drug Administration)
Executive suite: a spotlight on our clients' top performers.(Special Advertising Section)(Advertisement)
Novartis Pharma to Spin off Its Nutrition Business in January.
Alfresa Pharma to Become Distributor of Anafranil Antidepressant.
Novartis and Mochida Pharmaceutical to Co-promote Diovan in Japan.
Amgen KK.(BIOTECH)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles